project id: TCGA-COAD; case submitter id: TCGA-4N-A93T; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 67; days to birth: -24523; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1946; age at diagnosis: 24523; ajcc pathologic m: M0; ajcc pathologic n: N1b; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 146.0; icd 10 code: C18.2; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ascending colon; synchronous malignancy: No; tissue or organ of origin: Ascending colon; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 98; days to sample procurement: 0; initial weight: 290.0; portion submitter id: TCGA-4N-A93T-01A-11; percent lymphocyte infiltration: 12.0; percent monocyte infiltration: 4.0; percent necrosis: 10.0; percent neutrophil infiltration: 4.0; percent normal cells: 10.0; percent stromal cells: 35.0; percent tumor cells: 45.0; percent tumor nuclei: 75.0;